SCHEMBL423692

SCHEMBL423692

COc1c(Cl)cc(Cl)cc1C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACLY P53396 2/20 0.56
KDM4E B2RXH2 3/20 0.55
AKR1C4 P17516 1/20 0.55
AKR1C3 P42330 1/20 0.55
AKR1C2 P52895 1/20 0.55
AKR1C1 Q04828 1/20 0.55
TPMT P51580 1/20 0.51
HSD17B10 Q99714 2/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
MAPT P10636 1/20 0.48
ALDH1A1 P00352 3/20 0.47
TP53 P04637 1/20 0.47
TSHR P16473 1/20 0.47
CASP1 P29466 1/20 0.47
LMNA P02545 1/20 0.47
HPGD P15428 1/20 0.47
HTT P42858 1/20 0.47
MRGPRX4 Q96LA9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30084374 1.00 ACLY (0.56) ACLYKDM4EAKR1C4AKR1C3AKR1C2
SCHEMBL30239427 0.90 KDM4E (0.60) ACLYKDM4EAKR1C4AKR1C3AKR1C2
SCHEMBL10864147 0.85 KDM4E (0.48) ACLYKDM4EAKR1C4AKR1C3AKR1C2
SCHEMBL8427153 0.85 KDM4E (0.51) ACLYKDM4EAKR1C4AKR1C3AKR1C2
SCHEMBL1988952 0.83 KDM4E (0.54) ACLYKDM4EAKR1C4AKR1C3AKR1C2
SCHEMBL31325947 0.83 TPMT (0.50) ACLYKDM4EAKR1C3AKR1C2TPMT
SCHEMBL30810262 0.83 KDM4E (0.54) ACLYKDM4EAKR1C4AKR1C3AKR1C2
SCHEMBL10355676 0.83 KDM4E (0.71) ACLYKDM4EAKR1C4AKR1C3AKR1C2
SCHEMBL18393285 0.83 GALK1 (0.51) ACLYKDM4EHSD17B10SMN1; SMN2MEN1
SCHEMBL27859515 0.82 TPMT (0.53) ACLYKDM4ETPMTHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230157284-A1 HIGH-LOAD SOLUTION CONCENTRATES OF DICAMBA BASF CORPORATION 2023-05-25 US claimed
US-20230148590-A1 Aqueous Formulations of Dicamba BASF CORPORATION 2023-05-18 US claimed
US-20230145432-A1 AGROCHEMICAL FORMULATIONS BASF CORPORATION 2023-05-11 US claimed
EP-4132274-A1 HIGH-LOAD SOLUTION CONCENTRATES OF DICAMBA BASF Corporation (US) 2023-02-15 EP claimed
EP-4125378-A1 AGROCHEMICAL FORMULATIONS BASF Corporation (US) 2023-02-08 EP claimed
EP-4125365-A1 AQUEOUS FORMULATIONS OF DICAMBA BASF Corporation (US) 2023-02-08 EP claimed
CN-115426880-A Aqueous formulations of dicamba 巴斯夫公司 2022-12-02 CN claimed
CN-115361868-A High-load solution concentrates of dicamba 巴斯夫公司 2022-11-18 CN claimed
CN-115175562-A Agrochemical formulations 巴斯夫公司 2022-10-11 CN claimed
US-20220095612-A1 MICRONUTRIENT COMPOSITIONS AND SYSTEMS AND METHODS OF USING SAME NANOCHEM SOLUTIONS INC 2022-03-31 US claimed
WO-2021198458-A1 AQUEOUS FORMULATIONS OF DICAMBA BASF CORPORATION (US) 2021-10-07 WO claimed
WO-2021201838-A1 AGROCHEMICAL FORMULATIONS BASF CORPORATION (US) 2021-10-07 WO claimed
EP-0152216-A2 Herbicidal compositions and the selective control of weeds in cereal crops VELSICOL CHEMICAL LIMITED (GB) 1985-08-21 EP claimed
US-20230157284-A1 HIGH-LOAD SOLUTION CONCENTRATES OF DICAMBA BASF CORPORATION 2023-05-25 US disclosed
US-20230148590-A1 Aqueous Formulations of Dicamba BASF CORPORATION 2023-05-18 US disclosed
US-20230145432-A1 AGROCHEMICAL FORMULATIONS BASF CORPORATION 2023-05-11 US disclosed
US-4439229-A Substituted phthalimides herbicides ROHM AND HAAS COMPANY (US) 1984-03-27 US disclosed
US-4431437-A ADDING A PHYTOTOXICITY-PROMOTING MIXTURE OF N-METHYLPYRROLIDONE OR POLYVINYLPYRROLIDONE AND A 2-HALOETHYL PHOSPHONIC ACID GAF CORPORATION (US) 1984-02-14 US disclosed
EP-0068822-A2 Novel heterocyclic substituted benzenes, herbicidal compositions containing them and the use thereof for combating weeds ROHM AND HAAS COMPANY (US) 1983-01-05 EP disclosed
EP-0056261-A1 Bioactant translocation agent GAF CORPORATION (US) 1982-07-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230148590-A1 Aqueous Formulations of Dicamba BOLA2; BOLA2B, CIP2A, AQP1 ACLY 3230/4885KDM4E 3477/4885AKR1C4 2293/4885
US-20230157284-A1 HIGH-LOAD SOLUTION CONCENTRATES OF DICAMBA PDHB, PDHA1, LDHB ACLY 1583/4885KDM4E 1320/4885AKR1C4 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.